Leona Reilly

Leona Reilly adicionou um novo artigo Health
2025-07-30 10:00:39 - Traduzir

Cost-effective Animal Disease Models to Power Up Life Science Research
A wide range of cost-effective animal models, from Drosophila to non-human primates, from knockout models to different disease models, are released. In a pioneering effort to revolutionize life science research, a wide range of cost-effective animal disease models, from Drosophila to non-human primates, from knockout models to different disease models, are released. These groundbreaking...

0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!
Leona Reilly adicionou um novo artigo Health
2025-07-30 09:57:00 - Traduzir

Protheragen Unveils Revolutionary EndureCAR-T™ Cell Therapy Platform
Protheragen offers a variety of CAR-T cell therapy services, including personalized CAR-T cell analysis and therapy regimens based on a variety of disease models. Protheragen is an advanced CAR-T cell therapy service provider. With its extensive experience in cell therapy development and EndureCART™ technology platform, Protheragen provides investigators a wide range of disease models to...

0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!
Leona Reilly adicionou um novo artigo Health
2025-05-24 02:35:36 - Traduzir

Protheragen Launches Specialized Services to Support Research on Systemic Mitochondrial Disease
Protheragen, a leading biotechnology company specializing in advanced research services, announces its comprehensive suite of solutions designed to accelerate research and treatment development for Systemic Mitochondrial Disease. The company's specialized services address the complex challenges associated with these rare but devastating disorders. Systemic Mitochondrial Disease refers to...

0 Comentários 0 Compartilhamentos 4KB Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!
Leona Reilly adicionou um novo artigo Health
2025-05-24 02:33:46 - Traduzir

Protheragen Advances Gene Therapy Research with Comprehensive Adeno-Associated Virus (AAV) Vector Platform
Protheragen, a leading biotechnology company specializing in innovative genetic solutions, announced the expansion of its comprehensive Adeno-Associated Virus (AAV) Vector Platform services to meet the growing demands of gene therapy research and development. Adeno-associated virus (AAV) is a non-enveloped virus that can transport DNA to target cells through genetic engineering, and...

0 Comentários 0 Compartilhamentos 4KB Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!

Mais stories